Zimmer Presents Research Awards Focused on Women's Health Issues

SAN DIEGO, Feb. 15 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. , a worldwide leader in the orthopaedics industry, announced today that it has presented two $30,000 research awards specifically focused on women's musculoskeletal health issues. The awards were announced at the annual luncheon of The Ruth Jackson Orthopaedic Society (RJOS), an organization of orthopaedic surgeons dedicated to advancing women's health issues.

The RJOS luncheon is held in conjunction with the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS).

The Zimmer Research Award winners, who were selected by a committee of RJOS members, and the titles of their research projects, are:

Lisa Cannada, MD, Southwestern Medical Center (Dallas, TX), "Childbirth After Pelvic Fractures;" and Carla Smith, MD, PhD, The Neuromusculoskeletal Center of the Cascades (Bend, OR), "A Model for Optimizing Diagnosis and Treatment of Osteoporosis in a Community Setting: The Better Bone Health Partnership Project."

"We are pleased to recognize again this year the important work Ruth Jackson Society members are doing to advance the treatment of orthopaedic patients," said Ray Elliott, Zimmer Chairman, President and Chief Executive Officer. "Since introducing these research awards last year, Zimmer has increased its already sizable commitment to support advancements in women's musculoskeletal health. Our new Gender Solutions(TM) Knee, the first designed specifically for women, was recently described by 'Health Magazine' as 'one of the biggest breakthroughs in all of women's health.' Our internal development activities are now very much focused on addressing gender differences and our funding for external research into women's issues has substantially increased. We believe this focused collaboration with the profession has great potential for improving patient care."

The Ruth Jackson Orthopaedic Society is responsible for administering the Zimmer Research Award program. A panel of RJOS members reviews all award proposals and makes funding recommendations.

Earlier in the week, Zimmer sponsored the RJOS Practice Management Symposium, entitled "So You Think You Can Lead: Creating High Performance Teams." The symposium was led by noted author and educator Harvey Robbins, PhD. Further information about the Ruth Jackson Orthopaedic Society can be found on the RJOS website at http://www.rjos.org/.

About Zimmer

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is the worldwide #1 pure-play orthopaedic leader in designing, developing, manufacturing and marketing reconstructive and spinal implants, trauma and related orthopaedic surgical products. Zimmer has operations in more than 24 countries around the world and sells products in more than 100 countries. Zimmer's 2006 sales were approximately $3.5 billion. The Company is supported by the efforts of nearly 7,000 employees worldwide.

Visit Zimmer on the worldwide web at http://www.zimmer.com/ Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. These risks and uncertainties include, but are not limited to, our ability to successfully integrate acquired businesses, the outcome of the Department of Justice investigations announced in March 2005 and June 2006, price and product competition, rapid technological development, demographic changes, dependence on new product development, the mix of our products and services, supply and prices of raw materials and products, customer demand for our products and services, control of costs and expenses, our ability to conduct a successful search for a new chief executive officer, and the ability of the new chief executive officer to gain proficiency in leading our company, our ability to form and implement alliances, international growth, governmental laws and regulations affecting our U.S. and international businesses, including tax obligations and risks, product liability and intellectual property litigation losses, reimbursement levels from third-party payors, general industry and market conditions and growth rates and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. For a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

Contacts: Media Investors Brad Bishop Sean O'Hara Sam Leno 574-372-4291 574-371-8032 574-372-4790 bradley.bishop@zimmer.com sean.f.ohara@zimmer.com sam.leno@zimmer.com